Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 228

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 228
---
 which would reasonably be expected to |

| • |     | impede, materially delay or adversely affect the consummation of the Transactions or result in any of the          
 conditions to Enfusion’s obligations to consummate the Transactions not being fulfilled on or before the End Date; |

| • |     | result in a breach of any covenant, representation or warranty or any other obligation or agreement of Enfusion 
 contained in the Merger Agreement, or of such Significant Stockholder contained in the Support Agreement; or    |

| • |     | change in any manner the voting rights of any class of shares of Enfusion or Enfusion OpCo (including any 
 amendments to Enfusion’s certificate of incorporation or bylaws or the Operating Agreement); and          |

| • |     | any Acquisition Proposal. |

Pursuant to its Support Agreement, each Significant Stockholder appointed Clearwater as such Significant Stockholder’s attorney in fact and proxy with full power of substitution and resubstitution, and granted Clearwater the power to affirmatively vote all of its Subject Shares in favor of approving and adopting the Merger Agreement and the transactions contemplated thereby if, and only if, the Significant Stockholder fails to comply with the provisions of the Support Agreement. Additionally, subject to the terms and conditions of its Support Agreement, among other things, each Significant Stockholder is prohibited from transferring any of its Subject Shares until the termination of the Support Agreement. Each Significant Stockholder’s Support Agreement will terminate automatically upon the first to occur of (a) the valid termination of the Merger Agreement in accordance with its terms, (b) the Effective Time, (c) the date of any Prohibited Amendment (as defined below) that is effected without such Significant Stockholder’s prior written consent or (d) the written consent of such Significant Stockholder and Clearwater. A “ Prohibited Amendment” means any one or more amendments or modifications of any provision of the Merger Agreement 145

that (i) reduces the amount of the Merger Consideration or imposes any material restrictions or additional material conditions on the payment of the Merger Consideration, (ii) changes
the form of any consideration payable thereunder, (iii) changes the relative amount of cash and number of shares of Clearwater Common Stock payable under the Merger Agreement or (iv) amends or modifies certain provisions of the Merger
Agreement in a manner that would reasonably be expected to prevent (A) the Corporate Mergers, taken together, from qualifying as a reorganization within the